مؤسسة الوقاية من السرطان^® awards nine new research grants

للنشر الفوري
Contact: Lisa Berry Edwards
703-519-2107
Lisa.Edwards@preventcancer.org

Alexandria, VA—The Prevent Cancer Foundation is pleased to announce funding for nine scientists who are researching cancer prevention and early detection. Each scientist is being awarded $100,000 for two years. Areas of focus include the pancreas, esophagus, liver, lungs, skin, prostate, colon-rectum, and blood/bone marrow.

Here are the 2021 research grantees. Click here for more detailed information on their projects.

المستفيد:  Limor Appelbaum, M.D.
الجائزة المسماة: ألعاب رهيبة تم إنجازها بسرعة
موضع: Staff Scientist
Institution: Beth Israel Deaconess Medical Center, Boston, MA
Project Title: Use of medical records and microbiome for predicting pancreatic cancer

Pancreatic cancer is usually diagnosed in advanced stages when cure is no longer possible. Early detection of this cancer can lead to cure. Dr. Appelbaum proposes a model that can identify people at high risk of pancreatic cancer to be recommended for screening, which can potentially save lives.

المستفيد: Julie A. Barta, M.D., A.T.S.F.
الجائزة المسماة: Richard C. Devereaux Outstanding Young Investigator Award
موضع: Assistant Professor of Medicine
مؤسسة: Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA
Application Title: Improving lung cancer screening barriers for vulnerable populations

Despite the advent of lung screening to identify cancers at early, curable stages, major disparities exist in screening uptake and adherence. This project will examine and alleviate financial and technological barriers for vulnerable populations to increase lung cancer early detection and survival rates.

المستفيد: Neil Box, Ph.D.
موضع: أستاذ مشارك
Institution: University of Colorado Denver, Anschutz Medical Campus and Denver Campus, Denver, CO
عنوان المشروع: Integrating sun damage indicators in melanoma risk modeling

Dr. Box and his team will study how skin damaged by ultraviolet radiation can predict melanoma risk in children of certain genetic makeup. Their work will identify high-risk groups and prove the value of our tools in personalized melanoma prediction and prevention.

المستفيد: Sigrid Carlsson, M.D., Ph.D., M.P.H.
الجائزة المسماة: ألعاب رهيبة تم إنجازها بسرعة
موضع: مساعد أخصائي علم الأوبئة
مؤسسة: Memorial Sloan Kettering Cancer Center, New York, NY
Application Title: Improving prostate cancer screening using innovative technology

Dr. Carlsson and her team developed an innovative computer technology to help primary care physicians use “smarter” screening for prostate cancer for men who are most likely to benefit. The aim of this study is to test the usefulness of this computerized decision support tool in a large primary care network.

المستفيد: Margie Clapper, Ph.D.
موضع: Deputy Scientific Director/Professor/Co-Leader, Cancer Prevention and Control Program
Institution: The Research Institute of Fox Chase Cancer Center, Philadelphia, PA
عنوان المشروع: Impact of atorvastatin with or without aspirin on colorectal biomarkers in patients with Lynch Syndrome: a pilot study

Lynch Syndrome (LS) is the most common genetic cause of colon cancer in people under age 50. Atorvastatin reduces colon microadenomas dramatically in mice. Understanding the effect of atorvastatin with or without aspirin on colon biomarkers is critical to developing a preventive therapy for LS patients.

المستفيد: William Grady, M.D.
الجائزة المسماة: The Shure Family Charitable Foundation
موضع: Professor
مؤسسة: Fred Hutchinson Cancer Research Center, Seattle, WA
عنوان المشروع: Dysbiotic esophageal microbiomes and esophageal cancer risk

These studies have the potential to identify cancer-causing esophageal bacteria, which could lead to novel and improved ways to prevent cancer through more accurate cancer risk prediction. The studies could also lead to novel antibiotic or probiotic cancer prevention treatments for esophageal cancer.

Fellow: Natalia Heredia, Ph.D., M.P.H.
موضع: استاذ مساعد
مؤسسة: The University of Texas Health Science Center, Houston, TX 
الجائزة المسماة: مؤسسة مارسيا وفرانك كارلوتشي الخيرية
عنوان المشروع: Culturally tailored lifestyle intervention for Hispanic non-alcoholic fatty liver disease

The rate of new cases of liver cancer continues to increase in Hispanics, partially due to a condition called non-alcoholic fatty liver disease (NAFLD). Treatment for NAFLD includes weight loss, so by helping Hispanic NAFLD patients lose weight, we can prevent future cases of NAFLD-related liver cancer.

المستفيد: Maro Ohanian, D.O.
Named Award: Triad Foundation, LLC
موضع: استاذ مساعد
Institution: University of Texas M.D. Anderson Cancer Center, Houston, TX
عنوان المشروع: Detoxification of environmental metals to prevent acute myeloid leukemia

Toxic metals are a modifiable risk factor associated with increased cancer risk. Dr. Ohanian aims to reverse carcinogenic effects of environmental/occupational metal exposures that can lead to acute myeloid leukemia (AML) by detoxifying metals in patients with myelodysplastic syndrome (pre-leukemia) as a novel cancer prevention method.

Fellow: Aayushi Uberoi, Ph.D.
الجائزة المسماة: ألعاب رهيبة تم إنجازها بسرعة
موضع: Postdoctoral Scholar
Institution: University of Pennsylvania, Philadelphia, PA
عنوان المشروع: Modulating skin microbiota-host interactions to prevent UV-induced skin cancer

While the skin microbiome encounters the same ultraviolet B (UVB) exposure as the skin, the effects of UVB on the skin microbiome is unexplored. By exploring host-microbiome interactions during UVB-associated skin cancers, we can uncover a novel class of biomarkers and therapeutics for prevention of skin cancer.

حول مؤسسة الوقاية من السرطان^®

مؤسسة الوقاية من السرطان^® is celebrating 35 years as the only U.S. nonprofit organization focused solely on saving lives across all populations through cancer prevention and early detection.  Through research, education, outreach and advocacy, we have helped countless people avoid a cancer diagnosis or detect their cancer early enough to be successfully treated.

تنهض المؤسسة لمواجهة التحدي المتمثل في تقليل وفيات السرطان بمقدار 40% بحلول عام 2035. ولتحقيق ذلك، نحن ملتزمون باستثمار $20 مليون في التقنيات المبتكرة للكشف عن السرطان مبكرًا وتعزيز فحص السرطان المتعدد، و$10 مليون لتوسيع نطاق فحص السرطان والتطعيم. الوصول إلى المجتمعات المحرومة طبيًا، و$10 مليون لتثقيف الجمهور حول خيارات الفحص والتطعيم.

لمزيد من المعلومات، يرجى زيارة الموقع www.preventcancer.org.